Dr. Bernard Silver, M.D

Hematology & Oncology Cleveland, OH Male
NPI: 1093772691
Total Payments
$36,047
2022 Payments
$2,250
Companies
12
Transactions
56
Medicare Patients
626
Medicare Billing
$55,934

Payment Breakdown by Category

Consulting$26,441 (73.4%)
Travel$5,549 (15.4%)
Other$2,450 (6.8%)
Food & Beverage$1,508 (4.2%)
Education$99.00 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $26,441 7 73.4%
Travel and Lodging $5,549 15 15.4%
Honoraria $2,450 4 6.8%
Food and Beverage $1,508 29 4.2%
Education $99.00 1 0.3%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $9,641 13 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $9,120 9 $0 (2017)
AMAG Pharmaceuticals, Inc. $8,209 18 $0 (2018)
GENZYME CORPORATION $4,110 1 $0 (2020)
Takeda Pharmaceuticals U.S.A., Inc. $2,401 4 $0 (2022)
Dova Pharmaceuticals $1,344 2 $0 (2019)
Alexion Pharmaceuticals, Inc. $450.00 3 $0 (2021)
Bioverativ Therapeutics Inc. $353.65 1 $0 (2017)
Rigel Pharmaceuticals, Inc. $213.00 2 $0 (2018)
Amgen Inc. $99.00 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $2,250 1 Takeda Pharmaceuticals U.S.A., Inc. ($2,250)
2021 $150.00 1 Alexion Pharmaceuticals, Inc. ($150.00)
2020 $4,261 4 GENZYME CORPORATION ($4,110)
2019 $11,057 14 Shire North American Group Inc ($9,413)
2018 $3,187 10 AMAG Pharmaceuticals, Inc. ($2,879)
2017 $15,142 26 Boehringer Ingelheim Pharmaceuticals, Inc. ($9,120)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
03/15/2022 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,250.00 General
10/13/2021 Alexion Pharmaceuticals, Inc. Ultomiris (Drug) Honoraria Cash or cash equivalent $150.00 General
Category: Immunology
05/11/2020 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $4,110.00 General
01/23/2020 Takeda Pharmaceuticals U.S.A., Inc. — Travel and Lodging In-kind items and services $100.00 General
01/23/2020 Takeda Pharmaceuticals U.S.A., Inc. — Food and Beverage In-kind items and services $26.02 General
01/23/2020 Takeda Pharmaceuticals U.S.A., Inc. — Food and Beverage In-kind items and services $24.57 General
11/16/2019 Shire North American Group Inc — Consulting Fee Cash or cash equivalent $8,212.50 General
11/16/2019 Shire North American Group Inc — Travel and Lodging In-kind items and services $160.21 General
11/16/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $66.29 General
11/16/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $35.91 General
11/16/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $22.44 General
11/15/2019 Shire North American Group Inc — Travel and Lodging In-kind items and services $523.15 General
11/15/2019 Shire North American Group Inc — Travel and Lodging In-kind items and services $193.38 General
11/15/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $121.10 General
11/15/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $53.87 General
11/15/2019 Shire North American Group Inc — Food and Beverage In-kind items and services $23.76 General
09/11/2019 Alexion Pharmaceuticals, Inc. Soliris (Drug) Honoraria Cash or cash equivalent $150.00 General
Category: Immunology
06/27/2019 Alexion Pharmaceuticals, Inc. Soliris (Drug) Honoraria Cash or cash equivalent $150.00 General
Category: Immunology
06/06/2019 Dova Pharmaceuticals Doptelet (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: Hepatology
05/16/2019 Dova Pharmaceuticals Doptelet (Drug) Food and Beverage In-kind items and services $94.22 General
Category: Hepatology
12/02/2018 Rigel Pharmaceuticals, Inc. Tavalisse (Drug) Food and Beverage In-kind items and services $106.50 General
Category: Hematology
12/02/2018 Rigel Pharmaceuticals, Inc. Tavalisse (Drug) Food and Beverage In-kind items and services $106.50 General
Category: Hematology
04/18/2018 AMAG Pharmaceuticals, Inc. FERAHEME (Drug) Honoraria Cash or cash equivalent $2,000.00 General
Category: PARENTERAL IRON REPLACEMENT
04/18/2018 AMAG Pharmaceuticals, Inc. FERAHEME (Drug) Travel and Lodging In-kind items and services $285.85 General
Category: PARENTERAL IRON REPLACEMENT
04/18/2018 AMAG Pharmaceuticals, Inc. FERAHEME (Drug) Travel and Lodging In-kind items and services $284.40 General
Category: PARENTERAL IRON REPLACEMENT
123»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 128 171 $83,928 $12,321
2022 4 126 152 $68,848 $11,362
2021 6 200 236 $114,055 $19,103
2020 6 172 196 $87,586 $13,148
Total Patients
626
Total Services
755
Medicare Billing
$55,934
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 38 38 $36,408 $5,145 14.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 51 87 $23,586 $3,838 16.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 26 33 $13,827 $2,330 16.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 13 13 $10,107 $1,008 10.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 37 37 $26,640 $3,744 14.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 31 38 $14,412 $2,808 19.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 43 62 $15,216 $2,664 17.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 15 15 $12,580 $2,146 17.1%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 40 40 $23,984 $4,064 16.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 37 37 $30,892 $4,031 13.0%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 52 81 $19,363 $3,782 19.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 39 45 $17,623 $3,088 17.5%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 21 21 $15,956 $2,928 18.4%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 11 12 $6,237 $1,209 19.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 38 38 $28,272 $4,139 14.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 51 65 $23,656 $3,187 13.5%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 25 25 $13,700 $2,302 16.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 31 39 $9,017 $1,522 16.9%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 14 14 $7,496 $1,138 15.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 13 15 $5,445 $860.15 15.8%

About Dr. Bernard Silver, M.D

Dr. Bernard Silver, M.D is a Hematology & Oncology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093772691.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Silver, M.D has received a total of $36,047 in payments from pharmaceutical and medical device companies, with $2,250 received in 2022. These payments were reported across 56 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($26,441).

As a Medicare-enrolled provider, Silver has provided services to 626 Medicare beneficiaries, totaling 755 services with total Medicare billing of $55,934. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Cleveland, OH
  • Active Since 04/27/2006
  • Last Updated 02/05/2008
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1093772691

Products in Payments

  • FERAHEME (Drug) $8,209
  • PRADAXA (Drug) $2,410
  • Doptelet (Drug) $1,344
  • Eloctate (Drug) $353.65
  • Soliris (Drug) $300.00
  • Tavalisse (Drug) $213.00
  • Ultomiris (Drug) $150.00
  • VONVENDI (Biological) $132.93
  • Novoeight (Drug) $85.99
  • XTANDI (Drug) $20.00

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Cleveland

Hillard Lazarus, Md, MD

Hematology & Oncology — Payments: $2.5M

Hematology & Oncology $2.5M

Jorge Garcia, Md, MD

Hematology & Oncology — Payments: $765,093

Hematology & Oncology $765,093

Ronald Bukowski, Md, MD

Hematology & Oncology — Payments: $744,876

Hematology & Oncology $744,876

Balazs Halmos, Md, MD

Hematology & Oncology — Payments: $548,525

Hematology & Oncology $548,525

Dr. Dale Shepard, M.d., Ph.d, M.D., PH.D

Hematology & Oncology — Payments: $481,414

Hematology & Oncology $481,414

Bachar Dergham, Md, MD

Hematology & Oncology — Payments: $456,653

Hematology & Oncology $456,653